Starling Registry Study
Completed
- Conditions
- Hemodynamic Monitoring
- Interventions
- Device: Starling
- First Posted Date
- 2020-12-01
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 1207
- Registration Number
- NCT04648293
- Locations
- 🇺🇸
Baxter Investigational Site, Columbus, Ohio, United States
🇺🇸Mercy Hospital St. Louis, Saint Louis, Missouri, United States
🇺🇸Baxter Investigational SIte, Galveston, Texas, United States
Post-Market Study of Low-flow ECCO2R Using PrismaLung+
Not Applicable
Completed
- Conditions
- Mild to Moderate Acute Respiratory Distress Syndrome
- Interventions
- Device: PrismaLung+
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT04617093
- Locations
- 🇫🇷
Baxter Investigational Site, Vandœuvre-lès-Nancy, France
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
Phase 4
Completed
- Conditions
- Essential Fatty Acid Deficiency (EFAD)
- Interventions
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 101
- Registration Number
- NCT04555044
- Locations
- 🇺🇸
Baxter Investigational Site, Provo, Utah, United States
Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVA
Not Applicable
Terminated
- Conditions
- Healthy Volunteers
- Interventions
- Device: Peripheral intravenous analysis (PIVA) algorithm
- First Posted Date
- 2020-03-27
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 26
- Registration Number
- NCT04324593
- Locations
- 🇺🇸
Baxter Investigational Site, Miami, Florida, United States
Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac Output
Completed
- Conditions
- Cardiac Failure
- Interventions
- Device: Cova Patch
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT04255108
- Locations
- 🇺🇸
Cardiac ICU, Los Angeles, California, United States
Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Bioequivalance
- Interventions
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 196
- Registration Number
- NCT04155814
- Locations
- 🇺🇸
Baxter Investigational Site, Miami, Florida, United States
Efficacy and Safety of TISSEEL Lyo Compared to Manual Compression as an Adjunct to Haemostasis
Phase 3
Completed
- Conditions
- Adjunct to Hemostasis During Vascular Surgery
- Interventions
- Procedure: Manual compression with surgical gauze padsBiological: TISSEEL Lyo
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 104
- Registration Number
- NCT04083807
- Locations
- 🇷🇺
Baxter Investigational Site, Saint Petersburg, Russian Federation
Observational Study Using the CoVa Monitoring System 3
Completed
- Conditions
- Healthy
- Interventions
- Device: Cova Monitoring System 3
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 14
- Registration Number
- NCT03884582
- Locations
- 🇺🇸
toSense,Inc., San Diego, California, United States
Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line in Treatments of Patients With End-Stage Renal Disease (ESRD)
Not Applicable
Completed
- Conditions
- End-Stage Renal Disease
- Interventions
- Device: AK200 Ultra S, extracorporeal circulation conduct of blood purificationDevice: Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 276
- Registration Number
- NCT03859830
- Locations
- 🇨🇳
Investigational Site, Wenzhou, Zhejiang, China
Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)
Not Applicable
Terminated
- Conditions
- End Stage Renal Disease (ESRD)
- Interventions
- Device: AMIA APD Solution Generation System
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 22
- Registration Number
- NCT03812679
- Locations
- 🇺🇸
Investigational Site, Fitchburg, Wisconsin, United States
© Copyright 2025. All Rights Reserved by MedPath